LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis. Du Y, Geng G, Zhao C, Gao T, et al. BMC Cancer 2022;22:1145.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Du Y, Geng G, Zhao C, Gao T, et al. LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis. BMC Cancer 2022;22:1145.
PMID: 36344947